Citra Marga Nusaphala Persada Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Citra Marga Nusaphala Persada Tbk. trades at Rp1,370 (market cap 9.21T, 48.6K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Citra Marga Nusaphala Persada Tbk. is far larger — about 19.6× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 48.6K). Which is the better fit depends on your goals.
| CMNP | PRDL | |
|---|---|---|
Market Cap | 9.21T | 470.58B |
Volume | 48.6K | 28.43M |
Lot | 486 | 284.34K |
Turnover | 66.74M | 7.8B |
Average Price | 1,373.17 | 274.19 |
Value | 66.74M | 7.8B |
Indicative Equilibrium Price | 1,370 | 270 |
Indicative Equilibrium Volume | 7 | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Marga Nusaphala Persada Tbk (the Company) was established within the framework of the Domestic Investment Law No. 6 of 1968, as amended by Law No. 12 of 1970 based on Notarial Deed No. 58 dated April 13, 1987 of Kartini Muljadi, S.H.The Company derives its revenues primarily from tollgate proceeds, project management fees and, to a lesser extent, from services related to the operations of a toll way system. The Company started commercial operations on March 1990. On June 19th, 1996, the Tanjung Priok – Jembatan Tiga toll road started commercial operations.
Read more on CMNP →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →